Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0001104659-25-015319 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-16 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | — | +1,807 | 2,705 | +201% | — |
| D | 2025-02-19 | 2025-02-19 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | S - Sale+OE | $57.22 | -635 | 2,070 | -23% | -$36.3K |
| D | 2025-02-19 | 2025-02-16 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | $0.00 | -1,807 | 5,418 | -25% | $0 |
| DM | 2025-02-19 | 2025-02-14 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | A - Grant | $0.00 | +12.6K | 5,400 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-16 | M | A | 1,807 | — | 2,705 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F2) Includes 103 additional shares acquired under the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-02-19 | S | D | 635 | $57.22 | 2,070 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 1,807 | $0.00 | 5,418 | D | — · — to — | 1,807 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F6) The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. |
| 4 | Derivative | Restricted Stock Units | 2025-02-14 | A | A | 7,225 | $0.00 | 7,225 | D | — · — to — | 7,225 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F4) The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date. |
| 5 | Derivative | Stock Options (Right to Buy) | 2025-02-14 | A | A | 5,400 | $0.00 | 5,400 | D | $56.69 · — to 2035-02-13 | 5,400 Common Stock | (F5) The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. |